How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs

At a cancer conference in Chicago in June last year, a little-known Chinese startup stunned researchers with early results showing its experimental gene therapy was abating an aggressive form of blood cancer in patients back home.

Continue reading on The Wall Street Journal.